Please try another search
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Name | Age | Since | Title |
---|---|---|---|
Sergio Stevanato | 79 | - | Emeritus Chairman |
Paola Vezzaro | 54 | 2021 | Independent Director |
Donald Eugene Morel | 64 | 2018 | Independent Director |
Marco Stevanato | 50 | - | Vice Chairman |
Fabrizio J. Bonanni | 76 | 2013 | Independent Director |
Fabio Buttignon | 63 | 2014 | Independent Director |
Franco Stevanato | 49 | 2021 | Executive Chairman |
Alvise Spinazzi | 49 | 2011 | Director |
Madhavan Balachandran | 72 | 2018 | Independent Director |
Fabiano Nicoletti | 80 | 2003 | Independent Director |
William J. Federici | 63 | 2021 | Independent Director |
Franco Moro | 61 | 2019 | CEO & Director |
Luciano Santel | 68 | 2024 | Director |
Karen A. Flynn | 61 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review